The use of Trichomycin in the treatment of vulvovaginal mycosis in pregnant women☆

Add time:08/25/2019    Source:sciencedirect.com

The antibiotic, Trichomycin, proved to be highly effective as a self-administered therapeutic agent for the purpose of eliminating yeastlike fungi from the vaginal flora of pregnant women, and for establishing relief from subjective symptoms coincident with such infections.Although recrudescence was a common occurrence, relapses were shown to be preventable by continued topical treatment with Trichomycin in moderate dosage.Additional evidence derived from a series of vaginal biopsies is presented supporting the view that the syndrome of vulvovaginal mycosis is not the result of tissue invasion.It is suggested that an investigation into the possible role of other microorganisms in the etiology of nontrichomonal vaginitis might be fruitful, inasmuch as various yeast-like fungi have been found to be absent in a high proportion of such cases.

We also recommend Trading Suppliers and Manufacturers of Trichomycin A (cas 12698-99-6). Pls Click Website Link as below: cas 12698-99-6 suppliers

Prev:Comparison of candicidin, levorin and trichomycin by means of high-performance liquid chromatography
Next:Original articleComparison of gadofosveset (Vasovist®) with GADOBENATE DIMEGLUMINE (cas 12700-20-8) (Multihance®)-enhanced MR angiography for high-grade carotid artery stenosis)